RT Journal Article
SR Electronic
T1 Artificial intelligence assisted standard white light endoscopy accurately characters early colorectal cancer: a multicenter diagnostic study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.21.20025650
DO 10.1101/2020.02.21.20025650
A1 Meng, Sijun
A1 Zheng, Yueping
A1 Su, Ruizhang
A1 Wang, Wangyue
A1 Zhang, Yu
A1 Xiao, Hang
A1 Han, Zhaofang
A1 Zhang, Wen
A1 Qin, Wenjuan
A1 Yang, Chen
A1 Yan, Lichong
A1 Xu, Haineng
A1 Bu, Yemei
A1 Zhong, Yuhuan
A1 Zhang, Yi
A1 He, Yulong
A1 Qiu, Hesong
A1 Xu, Wen
A1 Chen, Hong
A1 Wu, Siqi
A1 Jiang, Zhenghua
A1 Zhang, Yongxiu
A1 Dong, Chao
A1 Hu, Yongchao
A1 Xie, Lizhong
A1 Li, Xugong
A1 Jiang, Jianping
A1 Zhu, Huafen
A1 Li, Wenxia
A1 Wen, Zhang
A1 Zheng, Xiaofang
A1 Sun, Yuanlong
A1 Zhou, Xiaolu
A1 Ding, Limin
A1 Zhang, Changhua
A1 Pan, Wensheng
A1 Wu, Shuisheng
A1 Hu, Yiqun
YR 2020
UL http://medrxiv.org/content/early/2020/02/23/2020.02.21.20025650.abstract
AB Colorectal cancer (CRC) is the third in incidence and mortality1 of cancer. Screening with colonoscopy has been shown to reduce mortality by 40-60%2. Challenge for screening indistinguishable precancerous and noninvasive lesion using conventional colonoscopy was still existing3. We propose to establish a propagable artificial intelligence assisted high malignant potential early CRC characterization system (ECRC-CAD). 4,390 endoscopic images of early CRC were used to establish the model. The diagnostic accuracy of high malignant potential early CRC was 0.963 (95% CI, 0.941-0.978) in the internal validation set and 0.835 (95% CI, 0.805-0.862) in external datasets. It achieved better performance than the expert endoscopists. Spreading of ECRC-CAD to regions with different medical levels can assist in CRC screening and prevention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMajor Science and Technology Project of Zhejiang Provincial 46 (2020C03030), Natural 47 Science Foundation of Fujian Province (2019-CXB-31), Science and technology program of Guangdong 48 Province (2016A020213002), and National Natural Science Foundation of China (81773956)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data would be available upon requests to corresponding authors.